Cerus Corp (CERS) Confirms FDA Approval of INTERCEPT Blood System for Plasma
Tweet Send to a Friend
Cerus Corporation (Nasdaq: CERS) announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE